Chaudhari U - Search Results

1

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody.

Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, Chaudhari U, Allen RS, Lizambri RG. Gottlieb AB, et al. Among authors: chaudhari u. J Am Acad Dermatol. 2002 Nov;47(5):692-700. doi: 10.1067/mjd.2002.124698. J Am Acad Dermatol. 2002. PMID: 12399760

2

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris.

Gottlieb AB, Masud S, Ramamurthi R, Abdulghani A, Romano P, Chaudhari U, Dooley LT, Fasanmade AA, Wagner CL. Gottlieb AB, et al. Among authors: chaudhari u. J Am Acad Dermatol. 2003 Jan;48(1):68-75. doi: 10.1067/mjd.2003.10. J Am Acad Dermatol. 2003. PMID: 12522373 Clinical Trial.

3

Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis.

Gottlieb AB, Chaudhari U, Mulcahy LD, Li S, Dooley LT, Baker DG. Gottlieb AB, et al. Among authors: chaudhari u. J Am Acad Dermatol. 2003 Jun;48(6):829-35. doi: 10.1067/mjd.2003.307. J Am Acad Dermatol. 2003. PMID: 12789171 Clinical Trial.

4

The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.

Gottlieb AB, Chaudhari U, Baker DG, Perate M, Dooley LT. Gottlieb AB, et al. Among authors: chaudhari u. J Drugs Dermatol. 2003 Jun;2(3):260-6. J Drugs Dermatol. 2003. PMID: 12848110 Clinical Trial.

5

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Chaudhari U, et al. Lancet. 2001 Jun 9;357(9271):1842-7. doi: 10.1016/s0140-6736(00)04954-0. Lancet. 2001. PMID: 11410193 Clinical Trial.

6

Benefits of mild cleansing: synthetic surfactant based (syndet) bars for patients with atopic dermatitis.

Solodkin G, Chaudhari U, Subramanyan K, Johnson AW, Yan X, Gottlieb A. Solodkin G, et al. Among authors: chaudhari u. Cutis. 2006 May;77(5):317-24. Cutis. 2006. PMID: 16776289 Clinical Trial.

7

Betamethasone valerate foam for treatment of nonscalp psoriasis.

Stein LF, Sherr A, Solodkina G, Gottlieb AB, Chaudhari U. Stein LF, et al. Among authors: chaudhari u. J Cutan Med Surg. 2001 Jul-Aug;5(4):303-7. doi: 10.1007/s10227-001-0006-0. Epub 2001 Jul 18. J Cutan Med Surg. 2001. PMID: 11907840 Clinical Trial.

8

Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.

Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, Robinson JG. Jones PH, et al. Among authors: chaudhari u. Am J Cardiol. 2016 Dec 15;118(12):1805-1811. doi: 10.1016/j.amjcard.2016.08.072. Epub 2016 Sep 14. Am J Cardiol. 2016. PMID: 27729106 Free article.

9

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. Among authors: chaudhari u. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.

10

Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II).

El Shahawy M, Cannon CP, Blom DJ, McKenney JM, Cariou B, Lecorps G, Pordy R, Chaudhari U, Colhoun HM. El Shahawy M, et al. Among authors: chaudhari u. Am J Cardiol. 2017 Sep 15;120(6):931-939. doi: 10.1016/j.amjcard.2017.06.023. Epub 2017 Jun 28. Am J Cardiol. 2017. PMID: 28750828 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page